Table 2.
Cohort studies
Author (ref) year subjects | Description of subjects | Travel type, duration | Subjects with VTE/total | Incidence (95% CI) | Standards met* | |
---|---|---|---|---|---|---|
Travelers/controls | Cases | |||||
Clerel10 1999 32,000,000 | Travelers: all arriving air passengers | Passengers transported to hospital from airport with confirmed PE diagnoses | Air, mean 12.7 h | PE: 15/32,000,000 | 0.5 (0.3–0.8) per million | 1,2,4,7 |
Lapostolle17 2001 135,290,000 | Travelers: all arriving air passengers | Passengers transported to hospital from airport with confirmed PE diagnoses | Air, <3 h | PE: 0/88,490,000 | 0.00 (0.0–0.04) per million† | 1,4,7,8 |
Air, >=3 to <6 h | PE: 1/9,180,000 | 0.11 (0.01–0.71) per million | ||||
Air, >=6 to <9 h | PE: 9/22,530,000 | 0.40 (0.19–0.79) per million | ||||
Air, >=9 to <12 h | PE: 33/12,370,000 | 2.66 (1.83–3.79) per million | ||||
Air, >= 12 h | PE: 13/2,720,000 | 4.77 (2.66–8.41) per million | ||||
Belcaro18 2001 778 | Travelers: volunteer passengers planning long distance air travel | Travelers with diagnosis of DVT from screening ultrasound exam | Air, 10–15 h | Low-risk‡ DVT: 0/355 | 0.0% (0.0–1.0)† | 2,6,7 |
High-risk‡ DVT: 11/389 | 2.8% (1.4–5.0) | |||||
Schwarz19 2002 320 | Travelers: volunteers planning long distance air travel | Subjects with diagnosis of DVT from screening ultrasound exam | Air, >8 h | DVT: 0/160 | 0.0% (0.0–2.3) | 2,3,4,6,7 |
Controls: age, sex matched nontraveling volunteers | – | DVT: 0/160 | 0.0% (0.0–2.3%) | |||
Schwarz20 2003 2,311 | Travelers: volunteers planning long-distance air travel | Subjects with diagnosis of DVT from screening ultrasound exam | Air, >8 h | DVT: 7/964 | 0.7% (0.3–1.5) | 2,3,4,6,7 |
Controls: nontraveling volunteers | – | DVT: 2/1,213 | 0.2% (0.02–0.6) | |||
Perez–Rodriguez21 2003 41,035,332 | Travelers: all arriving air passengers on international flights | Passengers transported to hospital from airport with confirmed PE diagnoses | Air, <6 h | PE: 0/28,038,726 | 0.00 per million† | 1,4,7,8 |
Air, 6–8 h | PE: 1/3,926,208 | 0.25 (0.00–0.75) per million | ||||
Air, >8 h | PE: 15/9,070,398 | 1.65 (0.81–2.49) per million | ||||
Hughes22 2003 878 | Travelers: volunteers planning long-distance air travel | Passengers with elevated D-dimer or symptoms suggestive of VTE during 3-mo follow-up period and VTE diagnosis confirmed by objective test | Air, 39.4 h (mean) | VTE: 9/878 PE: 4; DVT: 5 | 1.03% (0.5–1.9) | 2,4,6,7,8 |
Air, <24 h | VTE: 0/123 | 0.0% (0.5–3.0) | ||||
Air, >24 h | VTE: 9/752 | 1.2% (0.6–2.3) | ||||
Kelman23 2003 9,257,842 | Travelers: all arriving passengers on international flights | All inpatients with the discharge diagnosis of DVT or PE who had arrived on an international flight within 14 d | Air | VTE: 246/9,257,842 | 26.6 per million (23–30) | 1,4 |
Jacobson24 2003 899 | Travelers: volunteers planning long-distance air travel | Subjects with diagnosis of DVT from screening ultrasound exam | Air, 11 h | DVT: 0/434 | 0.0% (0.0–0.9) | 2,6 |
Gajic25 2005 8,860 | Travelers: patients having elective surgery after long-distance air travel | Patients having new-onset VTE within 28 d of Surgery | Air, >5,000 km | VTE: 11/223 | 4.9% (2.5–8.7)† | 4,7 |
Controls: patients having elective surgery but no long-distance air travel | <5,000 km | VTE: 13/8,637 | 0.2% (0.08–0.3) |
CI confidence interval, DVT deep venous thrombosis, VTE venous thromboembolism, PE pulmonary embolism, CTPA computed tomographic pulmonary arteriography, V/Q scan ventilation perfusion scan.
*See Appendix for explanation of standards.
†Differences between groups significant, P < 0.001.
‡Low risk: no known VTE risk factors; high risk: previous DVT, known coagulation disorder, severe obesity, limited mobility, cancer, large varicose veins.